Mark U. Rarick

4.6k total citations
48 papers, 2.7k citations indexed

About

Mark U. Rarick is a scholar working on Oncology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Mark U. Rarick has authored 48 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 15 papers in Genetics and 14 papers in Pathology and Forensic Medicine. Recurrent topics in Mark U. Rarick's work include Lymphoma Diagnosis and Treatment (14 papers), Viral-associated cancers and disorders (11 papers) and Chronic Lymphocytic Leukemia Research (7 papers). Mark U. Rarick is often cited by papers focused on Lymphoma Diagnosis and Treatment (14 papers), Viral-associated cancers and disorders (11 papers) and Chronic Lymphocytic Leukemia Research (7 papers). Mark U. Rarick collaborates with scholars based in United States, Canada and Germany. Mark U. Rarick's co-authors include Alexandra M. Levine, Parkash S. Gill, Marjorie Bernstein-Singer, Carmen L. Loureiro, Mark Krailo, Byron M. Espina, Parkash S. Gill, David H. Regan, Benjamin Djulbegović and Charles L. Bennett and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Diabetes Care.

In The Last Decade

Mark U. Rarick

48 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark U. Rarick United States 23 1.3k 745 628 397 384 48 2.7k
Anne Parker United Kingdom 23 1.1k 0.9× 1.0k 1.4× 768 1.2× 434 1.1× 460 1.2× 54 2.6k
Gordon L. Phillips United States 26 1.0k 0.8× 1.6k 2.1× 624 1.0× 514 1.3× 382 1.0× 87 3.8k
Semra Paydaş Türkiye 28 1.0k 0.8× 563 0.8× 633 1.0× 425 1.1× 274 0.7× 208 2.7k
Isaac Ben‐Bassat Israel 34 587 0.5× 1.3k 1.7× 674 1.1× 816 2.1× 282 0.7× 140 3.2k
Peter Mollee Australia 25 936 0.7× 841 1.1× 514 0.8× 444 1.1× 248 0.6× 180 2.5k
David H. Henry United States 19 619 0.5× 433 0.6× 358 0.6× 203 0.5× 153 0.4× 49 1.7k
Steven H. Kroft United States 29 775 0.6× 895 1.2× 1.1k 1.8× 910 2.3× 180 0.5× 119 2.9k
M Carotenuto Italy 26 680 0.5× 1.1k 1.4× 446 0.7× 609 1.5× 250 0.7× 81 2.2k
Chul Won Choi South Korea 28 851 0.7× 628 0.8× 664 1.1× 457 1.2× 198 0.5× 192 2.8k
Paul S. Ritch United States 38 2.9k 2.3× 218 0.3× 459 0.7× 322 0.8× 578 1.5× 133 4.6k

Countries citing papers authored by Mark U. Rarick

Since Specialization
Citations

This map shows the geographic impact of Mark U. Rarick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark U. Rarick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark U. Rarick more than expected).

Fields of papers citing papers by Mark U. Rarick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark U. Rarick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark U. Rarick. The network helps show where Mark U. Rarick may publish in the future.

Co-authorship network of co-authors of Mark U. Rarick

This figure shows the co-authorship network connecting the top 25 collaborators of Mark U. Rarick. A scholar is included among the top collaborators of Mark U. Rarick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark U. Rarick. Mark U. Rarick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chiappori, Alberto, Tatjana Kolevska, David R. Spigel, et al.. (2014). A randomized phase II study of the telomerase inhibitor imetelstat as maintenance therapy for advanced non-small-cell lung cancer. Annals of Oncology. 26(2). 354–362. 140 indexed citations
2.
Wolpin, Brian M., Eileen M. O’Reilly, Yoo-Joung Ko, et al.. (2013). Global, multicenter, randomized, phase II trial of gemcitabine and gemcitabine plus AGS-1C4D4 in patients with previously untreated, metastatic pancreatic cancer. Annals of Oncology. 24(7). 1792–1801. 29 indexed citations
3.
Raza, Azra, Naomi Galili, Scott E. Smith, et al.. (2011). A phase 2 randomized multicenter study of 2 extended dosing schedules of oral ezatiostat in low to intermediate‐1 risk myelodysplastic syndrome. Cancer. 118(8). 2138–2147. 36 indexed citations
4.
Rizzo, J. Douglas, Mark R. Somerfield, Karen L. Hagerty, et al.. (2007). Use of Epoetin and Darbepoetin in Patients With Cancer: 2007 American Society of Clinical Oncology/American Society of Hematology Clinical Practice Guideline Update. Journal of Clinical Oncology. 26(1). 132–149. 230 indexed citations
5.
Beer, Tomasz M., Celestia S. Higano, Mansoor N. Saleh, et al.. (2007). Phase II study of KOS-862 in patients with metastatic androgen independent prostate cancer previously treated with docetaxel. Investigational New Drugs. 25(6). 565–570. 37 indexed citations
6.
Ross, Helen J., Lowell L. Hart, Paul Swanson, et al.. (2006). A randomized, multicenter study to determine the safety and efficacy of the immunoconjugate SGN-15 plus docetaxel for the treatment of non-small cell lung carcinoma. Lung Cancer. 54(1). 69–77. 29 indexed citations
7.
Rarick, Mark U., Jonathan E. Kolitz, Jack Bernstein, et al.. (2001). Liposomal daunorubicin in the treatment of relapsed or refractory non-Hodgkin’s lymphoma. Annals of Oncology. 12(4). 457–462. 15 indexed citations
8.
Smith, Robert E., Ishmael Jaiyesimi, Luís Meza, et al.. (2001). Novel erythropoiesis stimulating protein (NESP) for the treatment of anaemia of chronic disease associated with cancer. British Journal of Cancer. 84(s1). 24–30. 69 indexed citations
9.
Gill, Parkash S., J Wernz, David T. Scadden, et al.. (1996). Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, and vincristine in AIDS-related Kaposi's sarcoma.. Journal of Clinical Oncology. 14(8). 2353–2364. 319 indexed citations
10.
Rarick, Mark U., et al.. (1992). Thrombotic thrombocytopenic purpura in patients with human immunodeficiency virus infection: A report of three cases and review of the literature. American Journal of Hematology. 40(2). 103–109. 39 indexed citations
11.
Gill, Parkash S., Marjorie Bernstein-Singer, Byron M. Espina, et al.. (1992). Adriamycin, bleomycin and vincristine chemotherapy with recombinant granulocyte—macrophage colony-stimulating factor in the treatment of AIDS-related Kaposiʼs sarcoma. AIDS. 6(12). 1477–1482. 28 indexed citations
12.
Rarick, Mark U., Amitabha Mazumder, Carmen L. Loureiro, et al.. (1991). Intravenous immunoglobulin in the treatment of human immunodeficiency virus‐related thrombocytopenia. American Journal of Hematology. 38(4). 261–266. 8 indexed citations
13.
Rarick, Mark U., et al.. (1991). The long-term use of zidovudine in patients with severe immune-mediated thrombocytopenia secondary to infection with HIV. AIDS. 5(11). 1357–1362. 14 indexed citations
14.
Gill, Parkash S., et al.. (1990). Treatment of Advanced Kaposiʼs Sarcoma Using a Combination of Bleomycin and Vincristine. American Journal of Clinical Oncology. 13(4). 315–319. 73 indexed citations
15.
Antoniskis, Diana, Robert A. Larsen, Bisher Akil, Mark U. Rarick, & John M. Leedom. (1990). Seronegative disseminated coccidioidomycosis in patients with HIV infection. AIDS. 4(7). 691–694. 20 indexed citations
16.
Gill, Parkash S., Mark U. Rarick, Byron M. Espina, et al.. (1990). Advanced acquired immune deficiency syndrome-related Kaposi's sarcoma. Results of pilot studies using combination chemotherapy. Cancer. 65(5). 1074–1078. 44 indexed citations
17.
Formenti, Silvia C., Parkash S. Gill, Mark U. Rarick, et al.. (1989). Primary central nervous system lymphoma in AIDS. Results of radiation therapy. Cancer. 63(6). 1101–1107. 101 indexed citations
18.
Gill, Parkash S., Bisher Akil, Patrick M. Colletti, et al.. (1989). Pulmonary Kaposi's Sarcoma: Clinical Findings and Results of Therapy. The American Journal of Medicine. 87(1). 57–61. 137 indexed citations
19.
Lukes, RJ, Marjorie Bernstein-Singer, Lauren Pinter‐Brown, et al.. (1988). Third-World Hodgkin's disease at Los Angeles County-University of Southern California Medical Center.. Journal of Clinical Oncology. 6(8). 1285–1292. 19 indexed citations
20.
Loureiro, Carmen L., Parkash S. Gill, Paul R. Meyer, et al.. (1988). Autopsy findings in AIDS-related lymphoma. Cancer. 62(4). 735–739. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anne Parker Breakdown of academic impact, for papers by Gordon L. Phillips Breakdown of academic impact, for papers by Semra Paydaş Breakdown of academic impact, for papers by Isaac Ben‐Bassat Breakdown of academic impact, for papers by Peter Mollee Breakdown of academic impact, for papers by David H. Henry Breakdown of academic impact, for papers by Steven H. Kroft Breakdown of academic impact, for papers by M Carotenuto Breakdown of academic impact, for papers by Chul Won Choi Breakdown of academic impact, for papers by Paul S. Ritch
Rankless by CCL
2026